SCHEMBL19784929

SCHEMBL19784929

CCCCc1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(-c5ccccc5)cc4)n3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.61
RARB P10826 6/20 0.57
ALDH1A1 P00352 3/20 0.50
MAPT P10636 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
NPC1 O15118 2/20 0.50
NFKB1 P19838 1/20 0.50
S1PR1 P21453 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RARA P10276 1/20 0.50
MTOR P42345 1/20 0.50
PSMB5 P28074 1/20 0.49
DHODH Q02127 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16152355 0.93 HSD11B1 (0.60) HSD11B1RARBALDH1A1MAPTRAB9A
SCHEMBL12628223 0.91 HSD11B1 (0.62) HSD11B1RARBALDH1A1MAPTRAB9A
SCHEMBL13539887 0.91 RAB9A (0.57) HSD11B1RARBALDH1A1MAPTRAB9A
SCHEMBL402463 0.89 HSD11B1 (0.68) HSD11B1RARBALDH1A1MAPTMEN1
SCHEMBL9158283 0.89 HSD11B1 (0.68) HSD11B1RARBALDH1A1MAPTMEN1
SCHEMBL28227628 0.88 HSD11B1 (0.56) HSD11B1RARBALDH1A1MAPTRAB9A
SCHEMBL11976436 0.87 RAB9A (0.55) HSD11B1RARBALDH1A1MAPTRAB9A
SCHEMBL23059656 0.87 HDAC2 (0.51) HSD11B1RARBALDH1A1MAPTRAB9A
SCHEMBL19034969 0.86 HSD11B1 (0.55) HSD11B1RARBALDH1A1MAPTRAB9A
SCHEMBL12622306 0.85 ALDH1A1 (0.63) HSD11B1RARBALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323181-B2 Composition containing phosphorescent compound and light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-06-18 US disclosed
US-20180123056-A1 LIGHT EMITTING DEVICE AND COMPOSITION USED FOR THIS LIGHT EMITTING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-03 US disclosed
US-20180016492-A1 COMPOSITION AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180123056-A1 LIGHT EMITTING DEVICE AND COMPOSITION USED FOR THIS LIGHT EMITTING DEVICE CHRM1, CRY1, L1CAM HSD11B1 981/4885RARB 1988/4885ALDH1A1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.